Ventas (NYSE:VTR) Now Covered by Analysts at Barclays

Equities researchers at Barclays assumed coverage on shares of Ventas (NYSE:VTR) in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage set an “equal weight” rating and a $99.00 price target on the real estate investment trust’s stock. Barclays‘s price target suggests a potential upside of 7.40% from the stock’s current price.

VTR has been the topic of a number of other research reports. UBS Group upped their target price on shares of Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research report on Monday, May 4th. Royal Bank Of Canada lifted their price target on shares of Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research report on Monday, May 4th. Raymond James Financial assumed coverage on shares of Ventas in a research note on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 price target on the stock. The Goldman Sachs Group restated a “buy” rating and issued a $110.00 price objective on shares of Ventas in a report on Tuesday, May 19th. Finally, Wells Fargo & Company increased their price objective on shares of Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Fifteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $96.17.

Ventas Trading Down 0.4%

Shares of Ventas stock opened at $92.18 on Tuesday. The stock has a 50 day moving average of $85.92 and a 200 day moving average of $83.23. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The firm has a market capitalization of $44.82 billion, a price-to-earnings ratio of 167.60, a PEG ratio of 1.99 and a beta of 0.70. Ventas has a fifty-two week low of $62.06 and a fifty-two week high of $93.05.

Ventas (NYSE:VTR) last posted its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. Ventas’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, research analysts predict that Ventas will post 3.88 earnings per share for the current year.

Insider Activity at Ventas

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of the company’s stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.53% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Capital World Investors acquired a new position in Ventas during the 4th quarter worth $594,116,000. Norges Bank purchased a new stake in shares of Ventas during the fourth quarter worth approximately $474,571,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Ventas by 32,509.3% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock valued at $359,722,000 after acquiring an additional 4,634,520 shares in the last quarter. Cohen & Steers Inc. raised its holdings in Ventas by 228.1% in the fourth quarter. Cohen & Steers Inc. now owns 4,606,355 shares of the real estate investment trust’s stock valued at $356,440,000 after acquiring an additional 3,202,323 shares in the last quarter. Finally, Daiwa Securities Group Inc. lifted its stake in Ventas by 188.7% in the fourth quarter. Daiwa Securities Group Inc. now owns 4,705,591 shares of the real estate investment trust’s stock worth $364,119,000 after acquiring an additional 3,075,450 shares during the last quarter. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.